United States
US 12,697,315 B2
Treatment for interstitial lung disease
US 12,697,315 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-04. Applicant: United Therapeutics Corporation. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- United Therapeutics Corporation
- Inventors
- Leigh Peterson; Peter Smith; Chunqin Deng
- Publication date
- 2026-08-04
- Filing date
- 2025-12-15
- Document type
- B2 Granted patent
- Also written as
- US 12,697,315 B2 · US12697315 · 12697315
Abstract
Methods of treating of interstitial lung disease, reducing pulmonary function decline in a subject with interstitial lung disease (ILD), and increasing forced vital capacity (FVC) in a subject suffering from ILD are provided, wherein the methods include administration of treprostinil.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free